Skip to main content
. 2016 Apr 28;11(4):e0154599. doi: 10.1371/journal.pone.0154599

Table 2. Comorbidities and procedures, according to obesity status.

Non-obese Obese p-value
Patients, n 1,551,000 212,000
Comorbidities, %
 AIDS 0.3 0.1 <0.001
 Alcohol abuse 4.4 3.2 <0.001
 Deficiency anemia 33.1 35.5 <0.001
 Rheumatoid arthritis/collagen vascular diseases 3.7 4.1 <0.001
 Chronic blood loss anemia 1.5 1.5 0.371
 Congestive heart failure 21.1 27.4 <0.001
 Chronic pulmonary disease 23.7 31.4 <0.001
 Coagulopathy 14.6 13.2 <0.001
 Depression 10.6 14.8 <0.001
 Diabetes uncomplicated 22.6 37.7 <0.001
 Diabetes complicated 8.0 16.7 <0.001
 Drug abuse 3.3 2.9 0.006
 Hypertension 54.8 67.6 <0.001
 Hypothyroidism 12.6 15.3 <0.001
 Liver disease 5.4 6.3 <0.001
 Lymphoma 2.1 1.2 <0.001
 Fluid and electrolyte disorders 55.6 54.2 0.002
 Metastatic cancer 5.2 2.4 <0.001
 Paralysis 7.2 5.3 <0.001
 Other neurological disorder 15.4 10.1 <0.001
 Peripheral vascular disorders 9.6 9.7 0.682
 Psychoses 5.2 7.2 <0.001
 Pulmonary circulation disorders 5.1 8.1 <0.001
 Renal failure 25.2 30.6 <0.001
 Solid tumor without metastasis 4.1 2.5 <0.001
 Peptic ulcer disease excluding bleeding 0.05 0.04 0.268
 Valvular diseases 6.7 5.9 <0.001
 Weight loss 20.4 16.3 <0.001
Procedure <0.001
 No major procedure 81.8 77.6
 Major diagnostic (Dx) procedure 0.6 0.7
 Major therapeutic (Tx) procedure 16.4 20.3
 Both major Dx and Tx procedures 1.2 1.4